SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-017019
Filing Date
2017-08-09
Accepted
2017-08-09 17:00:17
Documents
3
Period of Report
2017-08-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20170809.htm 8-K 32745
2 EX-99.1 abio-ex991_6.htm EX-99.1 19587
3 GRAPHIC g201708092002064894594.jpg GRAPHIC 20861
  Complete submission text file 0001564590-17-017019.txt   82522
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 171018699
SIC: 2835 In Vitro & In Vivo Diagnostic Substances